Catalyst Wire Dossier Catalyst Wire Dossier

E-SYNC CAR T cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E-SYNC CAR T cells, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells [Phase 1]

See pricing